Italian Association Amici di Raoul Follereau (AIFO)

Contact

General

Project Support

Alliances & Links

Resources & Training

ARCHIVES OF LEPROSY MAILING LIST
Archives of recent messages from Leprosy Mailing List (LML) managed by Dr Salvatore Noto.

Over the past few years, LML moderated by Dr Noto has become one of the most important online resource for promoting discussions about leprosy. For joining this mailing list kindly send an email to Dr. Salvatore Noto: salvatore.notoathsanmartino.it  (substitute at with @ in the email address)

Leprosy mailing list – August 21st, 2006

Ref.:   ILEP Technical Commission request for feedback on the need for a new text on leprosy
From
: Warren G., Sydney, Australia


 NB. Still problems with my e-mail.  Your feedback about quality of reception will be appreciated.


Dear Salvatore Noto,

Once again your correspondents have hit a jackpot.  Dr Ahmad L. of Karachi LML (July 25th, 2006) suggests that as there is a decline of leprosy in endemic areas there is no need for a new textbook.  Let us be frank.  The decline is in the number of patients technically on the WHO ”Leprosy patients List” and as yet there is not a great decrease in the total numbers of new patients diagnosed in many countries.  And there is certainly, as result of the publicity, a decrease in the training of doctors to be able to diagnose and treat leprosy.

One South African country achieved its goal of less than 1 per 10,000 of population some 15-20 years ago, but as yet there is really no decrease in the number of new patients diagnosed every year!  Do not suffer from delusions that leprosy is going!

The main problem as I see it is that there may well be, in the not too distant future, many relapsed patients who were given only 12 doses of MDT and some time later they relapse.  They state they have had treatment so the local GPs will not think seriously of leprosy as a diagnosis.

There is also the problem of the patient who having had the WHO MDT for a borderline type leprosy has, after MDT is completed, developed an upgrading reaction with acute neuritis. These are often poorly treated, often given only prednisolone and not another full course of MDT.  In the last 3 months, I have received queries about two such patients in Pakistan, where I assume Dr Ahmed is working.  In each case the patient is very distressed but was not getting adequate MDT for obviously active leprosy until I interfered!

Yes those methods for treatment, may not appear in WHO recommendations, but having worked in the Chinese racial group for 50 years I know that in some racial groups there are very few BB/BL or LL patients who even with full 3 drug MDT will completely recover with less that 3-4 years of treatment (not including the months in which they need steroids for nerve problems).  Yes it sounds a long time.  The number of relapses one sees over the next ten years will indicate the efficiency of any programme.

IN a number of counties in Asia, where I still work, I am witnessing patients relapsing with florid LL / BL leprosy after having been given so called full MDT for 12 -24 months and told they “were cured”.  This was completed up to 5 years pre my seeing them with very high bacillary index in skin smear.  No please someone do not tell me one does not use skin smears to diagnoses leprosy!  Some of the WHO papers say that “It is not necessary”.  It gives a positive diagnosis in many of the diffuse lepromatous patients when there are no definite skin lesions but the patient is highly infectious!  This is far more common in the Chinese and lighter skinned people with LL/BL leprosy, than in the dark skinned and many from the Indian sub continent in whom leprosy is more often on the TT / BT end of the spectrum) and, if these lepromatous patients were treated at once the patient may recover without any permanent disability.

Please consider the whole patient.  There are many who definitely have leprosy but do not satisfy the WHO criteria for registration.  They NEED TREATMENT NOW not in a couple of years when they have become a real problem.

We need a good practical book such as the Yawalkar book (originally a CIBA publication) that is small enough and cheap enough and has plenty of good coloured illustrations, of all skin colours, to spread widely to those learning leprosy now, and even more important to stimulate the younger generation to think leprosy when confronted with possible cases in the future in any area of the world.  Leprosy travels by air and in countries like Australia there are very few doctors who would even think of the possibility of leprosy for someone with dermatological rings!

There was a recommendation by Virmond M. (July 25th, 206), that each country ought to be responsible for putting relevant material into the various languages- excellent!

Please do not let us loose the experience we have gained over the last 40 years.  By suffering from the delusion that leprosy is on a serious decline.  Beware Leprosy is probably the cleverest organism we try to get rid of!  It will come back!  We cannot let everyone forget how to treat leprosy and to look for it early.  What can we do to try and improve the diagnosis of this disease for the next twenty years?  It will not be gone in that time!  We need a simple, small book that does give the essentials without a lot of hot air!

Grace Warren

<< BACK TO LML ARCHIVE INDEX

 

AIFO, Via Borselli 4-6, 40135 Bologna, Italy
Tel: +390-51-4393.211 Fax: +390-51-434046 Email: info@aifo.it